Literature DB >> 16342943

Structural analysis of silanediols as transition-state-analogue inhibitors of the benchmark metalloprotease thermolysin.

Douglas H Juers1, Jaeseung Kim, Brian W Matthews, Scott McN Sieburth.   

Abstract

Dialkylsilanediols have been found to be an effective functional group for the design of active-site-directed protease inhibitors, including aspartic (HIV protease) and metallo (ACE and thermolysin) proteases. The use of silanediols is predicated on its resemblance to the hydrated carbonyl transition-state structure of amide hydrolysis. This concept has been tested by replacing the presumed tetrahedral carbon of a thermolysin substrate with a silanediol group, resulting in an inhibitor with an inhibition constant K(i) = 40 nM. The structure of the silanediol bound to the active site of thermolysin was found to have a conformation very similar to that of a corresponding phosphonamidate inhibitor (K(i) = 10 nM). In both cases, a single oxygen is within bonding distance to the active-site zinc ion, mimicking the presumed tetrahedral transition state. There are binding differences that appear to be related to the presence or absence of protons on the oxygens attached to the silicon or phosphorus. This is the first crystal structure of an organosilane bound to the active site of a protease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16342943     DOI: 10.1021/bi051346v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Quantum chemical study of silanediols as metal binding groups for metalloprotease inhibitors.

Authors:  Igor S Ignatyev; Manuel Montejo; Pilar Gema Rodríguez Ortega; Juan Jesús López González
Journal:  J Mol Model       Date:  2013-01-15       Impact factor: 1.810

2.  Machine learning approach to discovery of small molecules with potential inhibitory action against vasoactive metalloproteases.

Authors:  Yudith Cañizares-Carmenate; Karel Mena-Ulecia; Desmond MacLeod Carey; Yunier Perera-Sardiña; Erix W Hernández-Rodríguez; Yovani Marrero-Ponce; Francisco Torrens; Juan A Castillo-Garit
Journal:  Mol Divers       Date:  2021-07-03       Impact factor: 2.943

3.  Silanetriols as in vitro inhibitors for AChE.

Authors:  Martina Blunder; Natascha Hurkes; Stefan Spirk; Martina List; Rudolf Pietschnig
Journal:  Bioorg Med Chem Lett       Date:  2010-11-05       Impact factor: 2.823

4.  Conformational sampling and kinetics changes across a non-Arrhenius break point in the enzyme thermolysin.

Authors:  Ming Dong; Mackenzie L Lauro; Timothy J Koblish; Brian J Bahnson
Journal:  Struct Dyn       Date:  2020-02-14       Impact factor: 2.920

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.